ArticleRSC applied interfaces2026
Surface properties of Ga-Cu based liquid-metal alloys: impact of Cu dilution, topography, and alloy liquefaction.
Article in RSC applied interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We studied the surface properties of Ga-Cu based liquid metal alloys - a promising material system for supported catalytically active liquid metal solutions (SCALMSs). The impact of Cu dilution in the (liquid) Ga matrix is in-detail investigated by X-ray and UV photoelectron spectroscopy (XPS/UPS) and machine-learned-force field (ML-FF) calculations. With decreasing Cu content, microscopic and macroscopic Ga-Cu model samples exhibit a shift of the Cu 2p core level line to higher binding energies (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.